Anti-sickling agents

Details Anti-sickling agents Anti-sickling agents

2006-10-10

2006-10-10

Solola, Taofiq (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C546S283700, C548S201000

Reexamination Certificate

active

07119208

ABSTRACT:
Compounds for the treatment of sickle-cell disease, and methods for their use are provided. The compounds have a dual mode of action. First, binding of the compounds to hemoglobin increases the oxygen affinity of both normal and sickle hemoglobin. Secondly, binding of these compounds to the N-terminal amino acid of sickle hemoglobin results in destabilization of potential contacts between sickle hemoglobin molecules, preventing polymerization and the formation of fibrous precipitates of the sickle hemoglobin. The compounds are also useful for inducing hypoxia, e.g. to augment cancer treatments.

REFERENCES:
patent: 4987132 (1991-01-01), Mase
patent: 6300332 (2001-10-01), Chang et al.

Affiliated with

Also associated with

Rating

Anti-sickling agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-sickling agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-sickling agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3650489